Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;24(3):757-765.
doi: 10.1111/hex.13246. Epub 2021 Apr 6.

Conducting public involvement in dementia research: The contribution of the European Working Group of People with Dementia to the ROADMAP project

Ana Diaz  1 , Dianne Gove  1 , Mia Nelson  2 , Michael Smith  2 , Claire Tochel  2 , Christophe Bintener  1 , Amanda Ly  2 , Christin Bexelius  3 , Anders Gustavsson  4 , Jean Georges  1 , John Gallacher  5 , Cathie Sudlow  2
Affiliations
Review

Conducting public involvement in dementia research: The contribution of the European Working Group of People with Dementia to the ROADMAP project

Ana Diaz et al. Health Expect. 2021 Jun.

Abstract

Background: Dementia outcomes include memory loss, language impairment, reduced quality of life and personality changes. Research suggests that outcomes selected for dementia clinical trials might not be the most important to people affected.

Objective: One of the goals of the 'Real world Outcomes across the Alzheimer's Disease spectrum for better care: Multi-modal data Access Platform' (ROADMAP) project was to identify important outcomes from the perspective of people with dementia and their caregivers. We review how ROADMAP's Public Involvement shaped the programme, impacted the research process and gave voice to people affected by dementia.

Design: The European Working Group of People with Dementia (EWGPWD) were invited to participate. In-person consultations were held with people with dementia and caregivers, with advance information provided on ROADMAP activities. Constructive criticism of survey content, layout and accessibility was sought, as were views and perspectives on terminology and key concepts around disease progression.

Results: The working group provided significant improvements to survey accessibility and acceptability. They promoted better understanding of concepts around disease progression and how researchers might approach measuring and interpreting findings. They effectively expressed difficult concepts through real-world examples.

Conclusions: The role of the EWGPWD in ROADMAP was crucial, and its impact was highly influential. Involvement from the design stage helped shape the ethos of the programme and ultimately its meaningfulness.

Public contribution: People with dementia and their carers were involved through structured consultations and invited to provide feedback on project materials, methods and insight into terminology and relevant concepts.

Keywords: Alzheimer's disease; dementia; patient empowerment; patient engagement; patient involvement; public participation.

PubMed Disclaimer

Conflict of interest statement

AG was a partner of Quantify Research, providing consultancy services to pharmaceutical companies and other private and public organizations and institutions. AG's contribution to ROADMAP was on behalf of Roche Pharmaceuticals. C Bintener received an honoraria from ProLog Wissen GmbH, Cologne, Germany, for a cognitive training programme.

References

    1. Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455‐532. - PubMed
    1. Scheltens P, Blennow K, Breteler MM, et al. Alzheimer's disease. Lancet. 2016;388(10043):505‐517. 10.1016/s0140-6736(15)01124-1 - DOI - PubMed
    1. Tochel C, Smith M, Baldwin H, et al. What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health‐care professionals? A systematic review. Alzheimers Dement (Amst). 2019;11:231‐247. 10.1016/j.dadm.2018.12.003 - DOI - PMC - PubMed
    1. Harding AJE, Morbey H, Ahmed F, et al. What is important to people living with dementia?: the ‘long‐list’ of outcome items in the development of a core outcome set for use in the evaluation of non‐pharmacological community‐based health and social care interventions. BMC Geriatr. 2019;19(1):94. - PMC - PubMed
    1. Harding AJE, Morbey H, Ahmed F, et al. Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non‐pharmacological community‐based health and social care interventions. Trials. 2018;19(1):247. 10.1186/s13063-018-2584-9 - DOI - PMC - PubMed

Publication types

LinkOut - more resources